Mandeep R. Mehra, MD, MSc, FRCP (London)
mrmcardsdoc.bsky.social
Mandeep R. Mehra, MD, MSc, FRCP (London)
@mrmcardsdoc.bsky.social
The William Harvey Chair in Advanced Cardiovascular Medicine at Brigham and Women’s Hospital and Professor of Medicine at Harvard Medical School
Reposted by Mandeep R. Mehra, MD, MSc, FRCP (London)
Patients with preexisting indications for aspirin therapy—including those with a history of revascularization, stroke, or PVD—may not need the drug after receiving the HeartMate 3 LVAD, according to new data from ARIES-HM3 #CardioSky @mrmcardsdoc.bsky.social

www.tctmd.com/news/vascula...
Vascular Disease History Need Not Preclude Aspirin Withdrawal After HeartMate 3
The ARIES-HM3 substudy may help persuade implanters who are less well-versed in the circulatory changes an LVAD affords.
www.tctmd.com
January 15, 2025 at 7:55 PM